Bunavail Approval History
- FDA approved: Yes (First approved June 6th, 2014)
- Brand name: Bunavail
- Generic name: buprenorphine and naloxone
- Dosage form: Buccal Film
- Company: BioDelivery Sciences International, Inc.
- Treatment for: Opiate Dependence
Bunavail (buprenorphine and naloxone) buccal film is an opioid analgesic/opioid antagonist formulation for the maintenance treatment of opioid dependence.
Development History and FDA Approval Process for Bunavail
|Jun 9, 2014||FDA Approves Bunavail Buccal Film for the Maintenance Treatment of Opioid Dependence|
|Oct 14, 2013||BioDelivery Sciences Announces FDA Acceptance of Bunavail NDA for Filing|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.